GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Inventories, Raw Materials & Components

AngioLab (XKRX:251280) Inventories, Raw Materials & Components : ₩0.0 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Inventories, Raw Materials & Components?

AngioLab's inventories, raw materials & components for the quarter that ended in Dec. 2023 was ₩0.0 Mil.

AngioLab's quarterly raw materials declined from Dec. 2021 (₩470.3 Mil) to Dec. 2022 (₩41.4 Mil) and declined from Dec. 2022 (₩41.4 Mil) to Dec. 2023 (₩0.0 Mil).

AngioLab's annual raw materials declined from Dec. 2021 (₩470.3 Mil) to Dec. 2022 (₩41.4 Mil) and declined from Dec. 2022 (₩41.4 Mil) to Dec. 2023 (₩0.0 Mil).


AngioLab Inventories, Raw Materials & Components Historical Data

The historical data trend for AngioLab's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Inventories, Raw Materials & Components Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 1,291.50 1,519.54 470.32 41.45 -

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial 1,291.50 1,519.54 470.32 41.45 -

AngioLab Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


AngioLab (XKRX:251280) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Inventories, Raw Materials & Components
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines